Read + Share
Amedeo Smart
Independent Medical Education
Babjuk M. Re: Erdafitinib in BCG-treated High-risk Non-muscle-invasive Bladder Cancer. Eur Urol 2024 Apr 9:S0302-2838(24)02262-0. doi: 10.1016/j.eururo.2024.PMID: 38599993
Email
LinkedIn
Facebook
Twitter
Privacy Policy